Zacks Investment Research - Logo

Zacks Marijuana Innovators Rides Wave After Wave of Legalization to Substantial Gains

You are invited to follow this portfolio's buys and sells in real time for the next 30 days.

Special opportunity ends midnight Sunday.

Special opportunity ends in .

The market for legal marijuana continues to expand. The Senate is on the brink of legalizing marijuana on the federal level after the Senate Majority Leader introduced draft legislation. 37 states have legalized medicinal marijuana. 18 states have made recreational use legal. With the passage of the Cannabis Act in 2018, it's now legal in Canada. Mexico's Supreme Court made private and recreational use legal in June of this year, though specific details of that legislation are still a bit unclear. As a result of these developments, companies within the space are about to take off.

In 2020, global revenue reached $24.6 billion. It's projected to skyrocket to $97.35 billion by 2026. More dispensary outlets are being opened, more products are on sale, and sales are especially booming for pharmaceutical cannabis, an essential business.

More than ever, this is the time to get in on Zacks Marijuana Innovators.

Portfolio Features

  • Buy & Sell Alerts
    update you via email or text message as soon as trades are added or removed from the portfolio.
  • Market Commentary
    briefs you on the latest developments and how they affect your trades.
  • Guide
    includes important tips to help you get the most out of the service's portfolio.
  • Strategy Focus
    Marijuana-Related
    Investments
  • Average Holdings
    12 to 15 stocks
  • Average Holding Period
    weeks to years
  • Trades Per Month
    2 to 4 trades
Average Return
+25.4% per year

Using Zacks Rank Profit Power

This service applies the timely predictive power of the Zacks Rank to buy and sell decisions. From January 1, 1988 to November 1, 2021 this proven system has more than doubled the S&P 500. The average gain has been +25.4% per year.

From $10,000 to More Than $21.4 Million

S&P 500 vs. Zacks #1 Rank List Hypothetical Return on 10K Investment: Jan 1, 1988 - Nov 1, 2021
$404,247 S&P 500
 
$21,410,684 Zacks #1
Rank List
The S&P 500 Index is owned and published by McGraw-Hill

Maybe +25.4% per year doesn't sound thrilling, but let's suppose you had invested $10,000 in the S&P 500 in 1988. Rebalancing monthly and not counting fees, you would have more than $400,000 today.

But if you had put that same $10,000 into the Zacks Rank system, it could have compounded to more than $21.4 million dollars.

Marijuana Innovators Builds on This Success

Ben Rains - Stock Strategist
Ben Rains
Marijuana Stock
Strategist

Ben Rains studied business management at Indiana University and earned his masters from DePaul University in Chicago a few years later. He has worked at Zacks as a Stock Strategist for five years, focusing on large-cap technology companies and consumer-facing stocks.

Rains currently helms the Marijuana Innovators trading service, searching for the latest strategies to expose investors to the growing legal market in the U.S. and beyond. He tailors his investments toward what's next, because the future is everything in long-term holdings.

That is how he closed recent gains like these:¹

  • +151.4% on Tilray, Inc. in 6 months
  • +147.0% on Innovative Industrial Properties, Inc. in 23 months
  • +39.7% on Aurora Cannabis Inc. in 5 months
  • +94.5% on GrowGeneration Corp.in 6 months

He's also riding impressive gains on several open positions and believes they still have a long way to go:¹

  • Stock #1: +151.43%
  • Stock #2: +90.8%
  • Stock #3: +10.2%
  • Stock #4: +9.6%

Total Cost for 30-Day Access to Marijuana Innovators: $1


Plus...That Same Dollar Brings You All Other Zacks Buys & Sells Through Zacks Ultimate

In other words, during your 30-day trial you can also sample:

  • All our short-term trading portfolios
  • All our long-term investing portfolios
  • All our private market insights
  • Zacks Premium research & tools
  • And more

No obligation beyond $1.
You may cancel at any time.


210 Double and Triple-Digit Gains This Year Alone

Here are some of the top, recently closed position from our short-term trading portfolios¹:

  • +70.9% in 5 days on CURO Group from Surprise Trader
  • +334.8% in 8 months on Anavex Life Sciences from Healthcare Innovators
  • +109.7% in 3 months on Johnson & Johnson from Options Trader
  • +130.0% in 4 months on Bed Bath & Beyond from Insider Trader
  • +92.9% in 8 months on Cowen Group from Blockchain Innovators
  • +148.3% in 5 months on ClevelandCliffs Inc. from Commodity Innovators
  • +54.3% in 2 months on Abercrombie & Fitch Company from Black Box Trader
  • +140.5% in 6 months on NVIDIA from TAZR

And several recent examples from our long-term investing portfolios¹:

  • +178.6% in 2½ months on Fiverr International Ltd. from Home Run Investor
  • +995.2% in 7 months on Cassava Sciences, Inc. from Stocks Under $10
  • +98.5% in 62 months on Quality Dividend Growth from ETF Investor
  • +386.8% in 12 months on Sea Limited ADR in Zacks Top 10 Stocks
  • +111.8% in 5 months on Aimmune Therapeutics, Inc. from Value Investor
  • +251.1% in 45 months on Microsoft from Income Investor

Free Bonus Report for Responding by Sunday

7 Best Stocks for the Next 30 Days

Taken from a proven list of 220 Zacks Rank #1 Strong Buys, this Special Report reveals 7 companies poised for immediate breakout. Each stock was selected because of its superior short-term profit potential under current market conditions.

5 Stocks Set to Double

In this Special Report five Zacks experts each recommend their single favorite stock predicted to increase +100% and more in the next 12 months. This is a must-read report for long-term investors.

5G: Top Stocks for the $12 Trillion Data Revolution

In this Special Report, Zacks experts explore a radical new technology set to change the world. The arrival of 5G has been called "the 4th Industrial Revolution" - and 3 breakthrough stocks could deliver potentially huge returns for early investors.

Century of Biology: 7 Biotech Stocks to Buy Right Now

Get Zacks's top 7 stocks to ride the $775 billion biotech revolution. Each of these picks could generate explosive gains in the coming months.

Early Warning Alert: Stocks to Sell Before They Report Earnings in the Coming Weeks

This Special Report reveals stocks that our system predicts will report the worst NEGATIVE earnings surprises from June 19 through July 30. If any of these tickers are among your holdings, consider getting rid of them now.

COVID-19 Investor's Guide: 5 Stocks to Profit from the "New Normal"

Get Zacks' top 5 stocks poised to profit from the changes unleashed by the Coronavirus outbreak. Each of these picks provides critical high-tech solutions and could generate explosive gains in the coming months.

Electric Vehicles - Profiting from the Wave of the Future

This timely alert pinpoints 3 established companies and 3 "upstarts" with almost unlimited gain potential in a space that's on fire.

Zacks Ultimate Four

These aren't just four promising stocks. They were hand-picked by Zacks experts to offer the greatest upside potential over the next quarter.

Zacks' 2020 Election Stock Report

Check out these trades with tremendous upside following the election (6 if Trump wins, 6 if Biden wins). The winner's policies and proposals will become powerful tailwinds from each of these picks — and investors could see double- or even triple-digit gains in the weeks after the votes are counted.

Presidential Profits: 5 Stocks To Ride Under the New Administration

Don't miss these trades with tremendous upside under the new Biden administration. His policies and proposals will become powerful tailwinds for each of these picks -- and investors could see double- or even triple-digit gains in the months ahead.

Investing For Impact: Zacks' 4 Hottest ESG Buys

Get Zacks' 4 hottest recommendations poised to profit from the skyrocketing demand for stocks focused on responsible, sustainable business practices. Each of these picks provides exceptional profit potential, decreased volatility. They could be among the most profitable stocks in your portfolio in 2020 and beyond.

Vaccine Miracles: 7 Stocks To Help Change the World

Zacks names 7 favorite stocks for explosive growth as companies race to develop innovative treatments.

How to Profit from Trillions in Spending for Infrastructure

Capitalize on America's rebuilding program with Zacks' top picks for the fast-approaching infrastructure boom. This Special Report names 7 stocks that look to benefit the most from trillions to be spent.

Travel Mega-Boom: 8 Stocks for the Trillion-Dollar Rebound

The travel industry lost .5 trillion due to the pandemic. Now that restrictions are lifting, consumers are making up for lost time, setting the stage for what could be the "rebound of the century." This special report reveals 8 stocks predicted to climb the highest.

5 Hottest IPOs to Watch in Q4

Zacks experts reveal critical insights into 5 companies that could hand investors triple-digit gains within weeks after they go public. Including one company that looks poised to have the biggest IPO in history.

Space Exploration: The Next Trillion-Dollar Industry

Get Zacks's top 4 stocks to buy as the space economy grows into a .7 trillion market (plus 4 non-stock profit plays). Each of these picks could generate tremendous gains in the coming months and for years to come.

Valued at $99, it is yours free when you start your 30-day trial.

See These Stocks »


Important: This Service is Closing to Public Entry

Important: To maximize the benefits of this service, we must limit the number of members who have access to its quick-reaction buys and sells. The portfolio closes to new investors midnight Sunday.

Start Your 30-Day Access »


Questions? Call toll-free at 1.888.775.8348 M-F, 9 am - 6 pm ET. Outside the U.S., 1.312.265.9309.

+Or click here for Frequently Asked Questions about this Zacks Ultimate opportunity.

What happens after my 30-day Zacks Ultimate trial is over?

You'll be notified at least seven days before your trial ends. You can choose to:

  • Simply walk away and owe us nothing. We'll be sorry to see you go, but we mean it when we say beyond $1 there is no obligation.
  • Let your Zacks Ultimate membership continue for only $299 per month.
  • Join this service and/or any of the individual portfolios.

Are there money-back guarantees?

You are backed with two assurances. The first is a Guarantee of Satisfaction. You may cancel up to 90 days after your $1 trial is over and if the service has not exceeded your expectations, then your money will be refunded - including the $1 you paid for the trial.

You will also be protected by a full-year, money-back Performance Guarantee. Details. That means if we don't help you beat the market, we'll refund your subscription.


What portfolios are included in Zacks Ultimate?

You gain real-time access to buys, sells, and market commentary from all of these private services:

  • Black Box Trader Automated stock-picking formula distills 10 high-potential performers from thousands of stocks each week.
  • Blockchain Innovators Zacks pursues massive gains from the emerging "Internet of Money" without the breakneck volatility of speculating in cryptocurrencies.
  • Commodity Innovators seeks both short and long-term profits on oil, gold, livestock, grains, currencies, and more at reduced risk. No futures or options, just easy-to-trade stocks and ETFs.
  • Counterstrike When High-Frequency Traders trigger panic sell-offs of good stocks, Zacks targets the best of them as they rebound.
  • ETF Investor Blending Zacks Industry Rank with its 2-to-1 performance advantage with the Zacks ETF Rank, it rides emerging trends without added risk and fees from buying stocks individually.
  • Headline Trader Fast-reflex portfolio gives you the jump on breaking news that ignites big stock moves. It focuses on companies that already show strong fundamentals and rising earnings estimates.
  • Healthcare Innovators Tracks breakthroughs in the pipeline throughout the healthcare sector - including pharmaceuticals, biotechnology, devices, hospitals, and more.
  • Home Run Investor Targets under-the-radar companies with over-the-top +50%, +100%, +200% potential. But it's watchful to prevent strike outs by cutting losers and providing diversity.
  • Income Investor Balances more aggressive moves with a steady flow of income through selected high-dividend stocks, plus other low-risk assets that offer higher potential than fixed income.
  • Insider Trader When significant insiders buy their own company's stock with their own money, it's an excellent signal - especially when combined with strong Zacks Rank timeliness and valuation factors.
  • Large-Cap Trader Selected large-cap stocks offer greater resistance to volatility than small caps, and yet can fly under-the-radar with strong growth potential.
  • Options Trader Blends the +25.4% yearly gain power of the Zacks Rank with professional options strategies to pursue substantial returns at a fraction of what would be risked on regular stock purchases.
  • Short Sell List Non-biased, computer-driven list of stocks primed to fall much more than average, making them excellent candidates for shorting - especially in bear markets.
  • Stocks Under $10 Pinpoints low-priced stocks with improving fundamentals and earnings outlooks for exceptional growth potential.
  • Surprise Trader Zacks' research breakthrough isolates the most accurate analyst "whispers" to call positive earnings surprises before they're reported with over 80% accuracy.
  • TAZR Technical Analysis + Zacks Rank blends the best of both worlds to catch a manageable handful of #1 and #2 stocks at the right time.
  • Technology Innovators Tracks emerging trends and breakthrough companies in fast-growing fields such as artificial intelligence, cloud computing, the Internet of Things, and more.
  • Value Investor Combining proven value criteria with Zacks Rank timing, it tracks undervalued companies until the market starts to see their real worth.
  • Zacks Confidential Each week, Zacks Executive VP Kevin Matras spotlights key trades and commentary from one of our hottest strategists so you can see Zacks' Best of the Best.
  • Zacks Premium Provides professional-grade tools to individual investors, featuring daily updates of the Zacks Rank, full access to Zacks Equity Research, Focus List portfolio of 50 stocks for the long haul, Premium Screens and much more.
  • Zacks Top 10 Stocks Compiles the best 10 stocks to buy and hold throughout the year. Each pick comes with in-depth research, and is actively managed with quarterly updates.

Will following all Zacks portfolio recommendations be hard work or "too much information?"

Not at all - most members start by quickly scanning each of the portfolios, and then simply narrow them down to the one(s) that suit them best.

Also, each day you receive a summary email that spotlights intraday trades and key market commentary from the various services.

And if you have any questions or need any help sorting out which portfolios are best for you, just pick up the phone and talk to a real person who can give you the info you need.

Ready to get started?

Since 2011, tens of thousands have taken advantage of this 30-day see-all experience. Don't miss this opportunity to discover the impact that the Zacks Rank can have on your portfolio.

It only costs $1. And not 1 cent of further obligation.

Get On The Waiting List Today

Marijuana Innovators is presently closed to new members, but new spots will become available soon.

Get on the waiting list now, and we'll contact you when a spot opens up.

No obligation, of course.

*All fields required